Peptides From China Catalog Customization Blog How It Works How to Pay Track Order FAQ Contact News

How to Read a Peptide COA: A Researcher’s Guide to HPLC and MS Reports

A technical guide to reading peptide COAs, comparing HPLC and MS evidence, checking batch linkage, and identifying documentation gaps.

How to Read a Peptide COA: A Researcher’s Guide to HPLC and MS Reports

A peptide Certificate of Analysis (COA) is a batch-linked technical record, not a universal guarantee. To read one responsibly, first establish whether the document can be linked to the material received, then determine what each method and result does—and does not—show.

Traceability before numbers

  • Match the product name, sequence or material description, batch or lot number, container label, and purchase record.

  • Identify the issuing laboratory or facility and confirm that the report is dated and signed or otherwise attributable.

  • Check that each critical analyte has a named method, numeric result where applicable, units, and a stated specification or interpretation.

  • Review production, test, issue, and retest dates for internal consistency; ask questions when the sequence of dates is unclear.

HPLC and mass spectrometry answer different questions

HPLC separates components and can provide a chromatographic purity or impurity profile under the stated conditions. Mass spectrometry can provide evidence relevant to molecular mass and identity. HPLC alone does not establish molecular identity, and MS alone does not describe the complete impurity profile or every quality attribute. The method, instrument conditions, sample preparation, and report scope matter when interpreting either result.

Purity is not the same as content or safety

A reported chromatographic purity percentage is not automatically the percentage of the labeled mass that is the intended peptide. Counterions, water, residual solvents, formulation components, and the basis of the calculation can affect delivered content. A COA also does not by itself establish sterility, endotoxin status, potency, stability, or suitability for human or animal use. Those questions require separate, appropriately documented evidence when relevant to the research protocol.

Document red flags

  • A missing or mismatched batch number, product description, date, unit, or method.

  • A summary result without the chromatogram, spectrum, specification, or other context needed to evaluate it.

  • Identical report identifiers, chromatogram images, or unusual formatting across unrelated batches.

  • An issuing laboratory or facility that cannot be identified, or a report that cannot be traced to the supplied material.

  • A request to treat a manufacturer or supplier document as independent testing.

Incoming-review workflow

At receipt, record the label and purchase order, compare them with the COA, and place the material on hold if the identifiers do not match. Review each critical row for method, result, units, and specification. Request the underlying chromatogram, spectrum, or method details when the result is material to the study and the report does not provide enough context. Where the laboratory protocol requires confirmation, arrange independent analytical testing and retain the result with the batch record.

PFC documentation scope

PFC coordinates manufacturer-side sourcing and international logistics. Manufacturer-side documentation may be available depending on the product and batch; PFC is not an independent analytical testing laboratory and does not guarantee a universal documentation package. The current minimum order is USD 600 in products, excluding shipping, and a USD 10 processing deposit begins manual availability verification and is credited toward the final invoice.

Research-use notice

Products discussed on this page are research-use materials only and are not for human or animal consumption. This page provides documentation guidance, not medical advice, dosing, administration, or treatment guidance.